Our history traced back to 2014, when a research team composed of postdoctoral fellows and scientists from multiple prestigious universities and institutions in the United States, including two postdoctoral fellows from the Lawrence Berkeley National Laboratory, a postdoctoral fellow from the California Department of Public Health, a professor from McMaster University, as well as Dr. Joshua Robinson and Academician Hongjie Dai from the U.S. National Academy of Sciences, was established in Joinn Innovation Park, located in the heart of Silicon Valley, California, USA. In the same year of November, we had research cooperation with Nirmidas and StartX (Stanford’s Accelerator) on Personal and Portable Health Diagnostic Testing. In the following year, our first colloidal analyzer passed the test from DCN, the authorized device test organization in the US.

Our research and development continued in the next few years with encouraging results by steady progress. In 2016, we developed colloidal gold test strip product antibodies in collaboration with ProMab and 2 patents obtained in the same year. In the next 3 years, we updated the version each year from Colloidal analyzer 2.0 version, Second Generation of colloidal analyzer: EHB-2.3 to version EHB3.0-EBH3.1.

When the COVID pandemic prevailed in 2020, our core team decided to move back to Germany. The R&D continued until our first hematology analyzer based on cell morphology technology came alive in 2021. Our brand story started by then...